AS SECOOND - LINE THERAPY WHEN DIET, EXERCISE AND INITIAL TREATMENT WITH A SULFONYLUREA DO NOT RESULT IN ADEQUATE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES.
AS SECOND LINE THERAPY WHEN DIET, EXCERCISE AND INITIAL TREATMENT WITH A SULFONYLUREA OR METFORMIN DO NOT RESULT IN ADEQUEATE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES.
- MUCOSAL CANDIDIASIS. THESE INCLUDE OROPHARYNGEAL, ESOPHAGEAL, NON INVASIVE BRONCHOPULMONARY INFECTIONS, CANDIDURIA,
- GENITAL CANDIDIASIS : VAGINAL CANDIDIASIS, ACUTE OR RECURRENT AND PROPHYLAXIS TO REDUCE THE INCIDENCE OF RECURRENT VAGINAL CANDIDIASIS
FOR THE TREATMENT OF DERMATITIS, INCLUDING ATOPIC DERMATITIS AND CONTACT DERMATITIS, WHERE AN INFECTION WITH BACTERIA SENSITIVE TO FUSIDIC ACID IS SUSPECTED OR CONFIRMED
ERYTHOMYCIN ETHYLSUCCINATE EQ.TO ERYTHOMYCIN 200 MG/5 ML
GRANULES FOR SUSPENSION
BOTTLE
IN THE TREATMENT OR PROPHYLAXIS OF THE FOLLOWING: UPPER AND LOWER RESPIRATORY TRACT INFECTIONS, SKIN AND SOFT TISSUE INFECTION INCLUDING GONORRHEA AND SYPHILLIS, INTESTINAL AMOEBIASIS, OTHER INCLUDE BACTERIAL ENDOCARDITIS, TREPTOCOCCAL PHAYNGITIS, DIPHTHERIA, LEGIONNAIRES'S DISEASE AND PERTUSSIA
EACH 10 ML CONTAINS: SODIUM ALGINATE 1000 MG, POTASSIUM BICARBONATE 200 MG
LIQUID
BOTTLE
TREATMENT OF SYMPTOMS OF GASTRO-OESOPHAGEAL REFLUX SUCH AS ACID REGURGITATION, HEARTBURN, INDIGESTION OCCURRING TO THE REFLUX OF STOMACH CONTENTS, FOR INSTANCE, AFTER GASTRIC SURGERY, AS A RESULT OF HIATUS HERNIA, DURING PREGNANCY OR ACCOMPANYING REFLUX OESOPHAGITIS.
